Related Experiment Video
Updated: Jun 19, 2026
08:25
Visualization of Streptococcus pneumoniae within Cardiac Microlesions and Subsequent Cardiac Remodeling
Published on: April 7, 2015
EXPERIMENTAL FOCALIZED MYOCARDIAL LESIONS PRODUCED WITH STREPTOCOCCUS MITIS.
1Pathological Laboratory of the Mount Sinai Hospital, New York.
The Journal of Experimental Medicine
|October 30, 2009
Summary
Injecting Streptococcus mitis into rabbits created focalized myocardial lesions, similar to those from Streptococcus rheumaticus and viridans, but distinct from epidemic streptococci and Aschoff bodies. These lesions are caused by bacterial toxins, not the organisms themselves.
Area of Science:
- Cardiology
- Microbiology
- Pathology
Background:
- Focalized myocardial lesions are a key feature in certain cardiovascular conditions.
- Understanding the causative agents and mechanisms of these lesions is crucial for diagnosis and treatment.
Purpose of the Study:
- To investigate the effects of Streptococcus mitis intravenous injection on rabbit myocardium.
- To compare the induced lesions with those caused by other streptococcal strains and known pathological markers like Aschoff bodies.
Main Methods:
- Intravenous injection of Streptococcus mitis into rabbits.
- Histopathological examination of myocardial tissue.
- Comparative analysis of induced lesions with existing literature and experimental models.
Main Results:
- Intravenous Streptococcus mitis induced focalized myocardial lesions in rabbits.
- These lesions were identical to those produced by Streptococcus rheumaticus and Streptococcus viridans.
- The induced lesions differed from those caused by epidemic streptococci and were distinguishable from Aschoff bodies.
- Evidence suggests myocardial lesions result from streptococcal toxins, not viable bacteria.
Conclusions:
- Streptococcus mitis can induce myocardial lesions in rabbits via toxins.
- The experimental lesions share focalized characteristics with human rheumatic carditis but are distinct from Aschoff bodies.
More Related Videos
Related Concept Videos
01:27Myocarditis II: Clinical Features and Diagnostic Tests
Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
01:21Myocarditis I: Introduction
Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
01:22Mitral Stenosis I: Introduction
Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
01:23Mitral Stenosis II: Clinical features and Diagnostic Tests
Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
01:14Myocarditis III: Medical Management
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
01:26Mitral Stenosis III: Medical Management
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...